Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
AstraZeneca continues to redefine cancer treatment at the 2019 ASCO Annual Meeting
-
Pooled analyses of the roxadustat global Phase III programme confirmed cardiovascular safety
-
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer, a population with high unmet need
-
Calquence Phase III ASCEND trial met primary endpoint at interim analysis in relapsed or refractory chronic lymphocytic leukaemia and will stop early
-
Qternmet XR approved in the US for the treatment of type-2 diabetes
-
AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
-
Lynparza receives positive EU CHMP opinion for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer
-
Q1 2019 Results
-
Lynparza approved in EU for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer
-
Positive results from Fasenra Phase II trial in hypereosinophilic syndrome published in New England Journal of Medicine
Latest articles and press releases
All of our latest press releases and articles are available to explore
